EMA — authorised 13 March 1997
- Marketing authorisation holder: Biogen Netherlands B.V.
- Status: approved
EMA authorised Avonex on 13 March 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 13 March 1997.
Biogen Netherlands B.V. holds the EU marketing authorisation.